Akira Nishijima

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian Cancer.

Mutational Signature-Based Biomarker for Phase II Trial of Olaparib Maintenance in Advanced High-Grade Ovarian Cancer.

Journal: Cancer science

Published: December 10, 2025

BRCA1 Promoter Methylation in Ovarian Cancer: Clinical Relevance and a Novel Diagnostic Approach Using Fragment Analysis.

BRCA1 Promoter Methylation in Ovarian Cancer: Clinical Relevance and a Novel Diagnostic Approach Using Fragment Analysis.

Journal: Cancer science

Published: February 03, 2025

Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics.

Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics.

Journal: Cancers

Published: November 18, 2023

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.

Integrated genomic/epigenomic analysis stratifies subtypes of clear cell ovarian carcinoma, highlighting their cellular origin.

Journal: Scientific reports

Published: August 12, 2023

Risk stratification of invasive cervical cancer diagnosed after cervical conization.

Risk stratification of invasive cervical cancer diagnosed after cervical conization.

Journal: Japanese journal of clinical oncology

Published: May 21, 2023

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer.

Heterogeneous effects of cytotoxic chemotherapies for platinum-resistant ovarian cancer.

Journal: International journal of clinical oncology

Published: March 31, 2023

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy.

Prognosis of patients with endometrial cancer or atypical endometrial hyperplasia after complete remission with fertility-sparing therapy.

Journal: Archives of gynecology and obstetrics

Published: March 03, 2023

Cancer of unknown primary histologically, genetically and spatially diagnosed as left ovary‑derived cancer: A case report.

Cancer of unknown primary histologically, genetically and spatially diagnosed as left ovary‑derived cancer: A case report.

Journal: Oncology letters

Published: February 28, 2023

Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.

Inhibition of protein arginine methyltransferase 6 activates interferon signaling and induces the apoptosis of endometrial cancer cells via histone modification.

Journal: International journal of oncology

Published: December 29, 2022

A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab.

A case of refractory pelvic squamous cell carcinoma of unknown primary that responded to nivolumab.

Journal: The journal of obstetrics and gynaecology research

Published: October 16, 2022

Suspicious Positive Peritoneal Cytology (Class III) in Endometrial Cancer Does Not Affect Prognosis.

Suspicious Positive Peritoneal Cytology (Class III) in Endometrial Cancer Does Not Affect Prognosis.

Journal: Journal of clinical medicine

Published: September 17, 2022

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study.

Effect of pelvic radiotherapy on patients with stage IB‑IIA cervical cancer after radical hysterectomy: A single‑center retrospective study.

Journal: Oncology letters

Published: August 11, 2022

Showing 1-12 of 18

Last Updated: 09/26/2026